Episode 21. IDDM with Dr Chin Tan
It is estimated that 130,000 Australians have been diagnosed with insulin dependent diabetes mellitus with about seven new cases per day. Approximately 60% of the diagnoses are in children and young adults under the age of 25 years. As IDDM is an autoimmune disease resulting in the destruction of insulin producing cells, glycaemic control is obtained through the administration of insulin. There have been several recent advances in continuous glucose monitoring and insulin delivery to review.
It is estimated that 130,000 Australians have been diagnosed with insulin dependent diabetes mellitus with about seven new cases per day. Approximately 60% of the diagnoses are in children and young adults under the age of 25 years. As IDDM is an autoimmune disease resulting in the destruction of insulin producing cells, glycaemic control is obtained through the administration of insulin. There have been several recent advances in continuous glucose monitoring and insulin delivery to review.
In this podcast episode we are joined by experienced endocrinologist Dr Chin Tan who will discuss:
· The importance of glycaemic control
· The choice of insulin
· Continuous glucose monitoring (CGM)
· Insulin pumps
I really enjoyed this conversation with Chin conducting it in his medical rooms and I was able to carefully inspect the latest gadgets that are available for IDDM patients. I am very pleased to bring this conversation to you.
Useful references include:
- southeasternendocrine.com
- www.ncbi.nlm.nih.gov
- www.aihw.gov.au
To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au
Dr Luke Crantock MBBS, FRACP, is a gastroenterologist in practice for over 25 years. He is the founder of The Centre for GI Health, based in Melbourne Australia and is passionate about educating General Practitioners and patients on disease prevention and how to manage and improve their digestive health.
Episode 15. Type 2 Diabetes with Dr Chin Tan
In this episode we have a conversation about Type 2 diabetes, a condition that affects at least 1.2 million Australians (5% of Australians) and for which there are a complex number of pharmacologic treatment strategies available.
In this episode, we have a conversation about Type 2 diabetes, a condition that affects at least 1.2 million Australians (5% of Australians) and for which there are a complex number of pharmacologic treatment strategies available.
We are joined by experienced and very popular Endocrinologist Dr Chin Tan who discusses –
· Oral hypoglycaemic agents that are available to us in Australia
· How to combine these agents for effective glycaemic control
· The place of insulin in type 2 diabetes
Chin also discusses the broader metabolic syndrome and the key requirement for BMI control in type 2 diabetic patients.
This is a detailed conversation which I hope you will find very informative.
Useful references include –
www.southeastendocrine.com
To be a guest on the show or provide some feedback, I’d love to hear from you: manager@gihealth.com.au